In China, the recent outbreak of hospitalizations due to childhood pneumonia has attracted the attention of the World Health Organization (WHO). The primary cause appears to be Mycoplasma pneumoniae. In the height of influenza season, should we be concerned about this pathogen? Here are five questions to understand.
Comments closedThe US Centers for Disease Control and Prevention (CDC) today issued its initial risk assessment of the BA.2.86 SARS-CoV-2 lineage, which says tests and treatments will likely be effective and that updated vaccines will still be able to reduce severe disease and hospitalizations.
Comments closed“It is unusual for [this virus] to change so significantly and develop 30 new mutations. The last time we saw such a big change was when [Omicron] appeared.”
Comments closedThe World Health Organization and US health authorities announced on Friday that they were closely monitoring a new variant of the COVID-19 virus, although “for the time being, the potential impact of the many mutations in BA.2.86 is unknown.”
Comments closedThe U.S. Centers for Disease Control and Prevention announced Thursday it is tracking a recently discovered COVID-19 strain, BA.2.86, after a case of the highly mutated variant was discovered in Michigan.
Comments closedCOVID-19 positive outpatients are at an increased risk of neurodegenerative disorders compared with individuals who tested negative for the virus, a new study presented today at the 8th European Academy of Neurology (EAN) Congress has shown.
The study, which analysed the health records of over half of the Danish population, found that those who had tested positive for COVID-19 were at an increased risk of Alzheimer’s disease, Parkinson’s disease, and ischaemic stroke.
Comments closed